Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-09

FDA Approved: BUDESONIDE INHALATION — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals’ original application for budesonide inhalation, a generic inhaled corticosteroid for the maintenance treatment of asthma. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide Inhalation (Budesonide)

Snippet

ORIG AP for BUDESONIDE INHALATION (BUDESONIDE INHALATION)